Picture Berlin Partner German Biotech Days 2024 in Berlin 650x100px
Document › Details

Biovian Oy. (9/6/22). "Press Release: Biovian Appoints Its First US-based Business Development Manager".

Organisations Organisation Biovian Oy
  Organisation 2 Cellectis Inc.
  Group Cellectis (Group)
Products Product contract manufacturing (biologicals)
  Product 2 viral vector production technology
Persons Person Allen, Allison (Biovian 202209– Business Development Manager based in US before Cellectis + Alcami + Thermo Fisher)
  Person 2 Nieminen, Antti (Biovian 202303 CEO + Co-Founder)

Biovian welcomes Allison Allen to drive new market entry and client acquisition in the worlds largest viral vector market

Biovian, a Nordic Bio-CDMO committed to providing premium One-Stop-Shop GMP services to biotech companies, is delighted to announce that Allison Allen based in North Carolina has been appointed Business Development Manager. Ms. Allen will be a strong addition to the business and marketing team and will be giving her contribution to the growth acceleration of the company. In her position Ms. Allen will be responsible for identifying new business opportunities within predominately the North American market with a focus on the US.

“We are very pleased that Allison Allen will assume the role of Business Development Manager at Biovian” Antti Nieminen, CEO of Biovian, states. “Her background and understanding of the North American Viral Vector market make Ms. Allen an excellent fit for this important role. We look forward to working with her as we continue to implement Biovian’s viral vector growth objective.”

Prior to joining Biovian Allison Allen worked as Director of Project Management for Cellectis with the objective of leading the technical transfer of company-owned products to the new manufacturing facility in Raleigh, NC. Allison has a wealth of experience in the CDMO business from his previous roles. At Alcami she led the project management and also served on the site leadership team. She has also worked at Thermo Fisher, Emergent, and Paragon.

About Biovian

Biovian is a CDMO that provides premium services to biotech companies developing innovative gene therapies or biopharmaceuticals. Biovian offers its clients a One-Stop-Shop GMP CDMO service, with modularity available from gene to finished vial. Biovian is especially focusing on Viral Vector production, microbial production of recombinant proteins, and GMP plasmid DNA. Guided by its Nordic ethos Biovian has established a reputation for delivering high-quality work on time and within budget to a global client base. Additional information is available at

Communication Contact:

Dr. Magnus Gustafsson, CBO
+46 70 723 1010/

Record changed: 2024-01-06


Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Biovian Oy

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x300px

» top